Strong Association of Metabolic Parameters with ADMA and VCAM-1 in Normo-Weight Subjects with Metabolic Syndrome

References

• Chigom E. Non-communicable diseases. World Health. 1988.
   Google Scholar
• Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of Metabolic Syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109(3):433–438. doi:10.1161/01.CIR.0000111245.75752.C6
   PubMed Web of Science ®Google Scholar
• Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:1–21. doi:10.1155/2014/943162
   Google Scholar
• Pullaiah CP, Reddy DG. Metabolic Syndrome: a Rising Epidemic: comprehensive Review. Int J Res Ayurveda Pharm. 2017;8(3):36–41. doi:10.7897/2277-4343.083140
   Google Scholar
• Dearborn JL, Viscoli CM, Inzucchi SE, Young LH, Kernan WN. Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease. Int J Stroke. 2019;14(6):639–645.
   PubMed Web of Science ®Google Scholar
• Shi TH, Wang B, Natarajan S. The influence of metabolic syndrome in predicting mortality risk among US adults: importance of metabolic syndrome even in adults with normal weight. Prev Chronic Dis. 2020;17:1–10. doi:10.5888/pcd17.200020
   Web of Science ®Google Scholar
• Mata AJ, Jasul G. Prevalence of metabolic syndrome and its individual features across different (Normal, overweight, pre-obese and obese) body mass index (BMI) categories in a tertiary hospital in the Philippines. J ASEAN Federation Endocrine Societies. 2017;32:117–122. doi:10.15605/jafes.032.02.04
   PubMedGoogle Scholar
• Ding C, Chan Z, Magkos F. Lean, but not healthy. Curr Opin Clin Nutr Metab Care. 2016;19(6):408–417. doi:10.1097/MCO.0000000000000317
   PubMed Web of Science ®Google Scholar
• Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47(5):699–713. doi:10.2337/diabetes.47.5.699
   PubMed Web of Science ®Google Scholar
• Kim NH, Kim KJ, Choi J, Kim SG. Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity. Metabolism. 2022;128(January):154894. doi:10.1016/j.metabol.2021.154894
   PubMedGoogle Scholar
• Suliga E, Kozieł D, Głuszek S. Prevalence of metabolic syndrome in normal weight individuals. Ann Agric Environ Med. 2016;23(4):631–635. doi:10.5604/12321966.1226858
   PubMed Web of Science ®Google Scholar
• Eliana F, Suwondo P, Makmun LH, Kunci K. Faktor risiko disfungsi endotel pada prediabetes The risk factor of endothelial dysfunction in prediabetes. J Kedokt Yars. 2009;17(3):160–168.
   Google Scholar
• Hardiman D, Medika M. Metformin Dosis Rendah Jangka Pendek dan Risiko Timbulnya Aterosklerosis pada Prediabetes. Int J Med. 2010;43(2):69–74.
   Google Scholar
• Sibal L, Agarwal C, Sd H, Boger PH. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev. 2010;6(2):82–90. doi:10.2174/157340310791162659
   PubMedGoogle Scholar
• Palomo I, Contreras A, Alarcón LM, et al. Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide - Biol Chem. 2011;24(4):224–228. doi:10.1016/j.niox.2011.03.002
   PubMed Web of Science ®Google Scholar
• Kemenkes. Epidemi Obesitas. FactSheet_Obesitas_Kit_Informasi_Obesitas.pdf. 2021. 1–8.
   Google Scholar
• Fathurrahman M. Hubungan Asymmetric Dimethylarginine (Adma) Dengan Hasil Luaran Bayi Pada Pasien Dengan Preeklamsia. 2017.
   Google Scholar
• Gupta G, Wadhwa R, Pandey P, et al. Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance. Pathophysiology of Obesity-Induced Health Complications. Cham. Springer International Publishing. 2020 81–97. Available from: http://www.springer.com/series/7064. Accessed February 13, 2024.
   Google Scholar
• Martyn JAJ, Kaneki M, Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology. 2008;109(1):137–148. doi:10.1097/ALN.0b013e3181799d45
   PubMed Web of Science ®Google Scholar
• Toelsie JR, Morpurgo F, Krishnadath I, Bipat R. Obesity, overweight and hyperglycemia among primary school children in a low-middle income country with a multiethnic population. Obes Pillars. 2023;5(November 2022):100053. doi:10.1016/j.obpill.2022.100053
   PubMedGoogle Scholar
• Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, Home PD. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. Cardiovasc Diabetol. 2009;8(1):1–7. doi:10.1186/1475-2840-8-27
   PubMedGoogle Scholar
• Couffinhal T, Duplàa C, Moreau C, Lamazière JMD, Bonnet J. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res. 1994;74(2):225–234. doi:10.1161/01.RES.74.2.225
   PubMed Web of Science ®Google Scholar
• Medina-leyte DJ, Zepeda-garc O, Dom M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021;22(8):1–28. doi:10.3390/ijms22083850
   Web of Science ®Google Scholar
• Li L, Chu Y, Fink GD, Engelhardt JF, Heistad DD, Chen AF. Endothelin-1 Stimulates Arterial VCAM-1 Expression Via NADPH Oxidase-Derived Superoxide in Mineralocorticoid Hypertension. Hypertension. 2003;42(5):997–1003. doi:10.1161/01.HYP.0000095980.43859.59
   PubMed Web of Science ®Google Scholar
• Abraham D, Distler O. How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther. 2007;9(SUPPL. 2):S2. doi:10.1186/ar2186
   PubMedGoogle Scholar
• Maloberti A, Bruno RM, Facchetti R, et al. THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS. Eur J Intern Med. 2020;76(February):107–109. doi:10.1016/j.ejim.2020.02.005
   PubMedGoogle Scholar
• Maloberti A, Bombelli M, Vallerio P, et al. Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects. Nutr Metab Cardiovasc Dis. 2021;31(4):1044–1052. doi:10.1016/j.numecd.2020.11.011
   PubMed Web of Science ®Google Scholar
• Nursalim A, Yuniadi Y. Paradox Obesitas pada Pasien Gagal Jantung. J Kardiol Indones. 2011;32(4):207–215.
   Google Scholar
• Cheung Y-M, Joham A, Marks S, Teede H. The obesity paradox: an endocrine perspective. Intern Med J. 2017;47(7):727–733. doi:10.1111/imj.13257
   PubMed Web of Science ®Google Scholar
• Elagizi A, Kachur S, Lavie CJ, et al. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. Prog Cardiovasc Dis. 2018;61(2):142–150. doi:10.1016/j.pcad.2018.07.003
   PubMed Web of Science ®Google Scholar
• Zhang LF, Zalewski A, Liu Y, et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 2003;108(4):472–478. doi:10.1161/01.CIR.0000080378.96063.23
   PubMed Web of Science ®Google Scholar
• Gustavsson C, Agardh CD, Zetterqvist AV, Nilsson J, Agardh E, Gomez MF. Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One. 2010;5(9):1–12. doi:10.1371/journal.pone.0012699
   Web of Science ®Google Scholar
• Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med. 2012;2012:8267. doi:10.1155/2012/918267
   Google Scholar
• Hadi HAR, Al Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3(6):853–876.
   PubMedGoogle Scholar
• Wadham C, Parker A, Wang XP. High Glucose Attenuates Protein S -Nitrosylation in. Diabetes. 2007;56(November):2715–2721. doi:10.2337/db06-1294
   PubMedGoogle Scholar
• Virtanen KA, Iozzo P, Hällsten K, et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. Diabetes. 2005;54(9):2720–2726. doi:10.2337/diabetes.54.9.2720
   PubMed Web of Science ®Google Scholar
• Rakhmat II, Putra ICS, Wibowo A, et al. Cardiometabolic risk factors in adults with normal weight obesity: a systematic review and meta‐analysis. Clin Obes. 2022;12(4). doi:10.1111/cob.12523
   PubMed Web of Science ®Google Scholar
• Kamso S, Purwantyastuti P, Lubis DU, Juwita R, Robbi YK, Besral B. Prevalensi dan Determinan Sindrom Metabolik pada Kelompok Eksekutif di Jakarta dan Sekitarnya. Kesmas Natl Public Heal J. 2011;6(2):85. doi:10.21109/kesmas.v6i2.110
   Google Scholar
• Zahtamal Z, Prabandari YS, Setyawati L. Prevalensi Sindrom Metabolik pada Pekerja Perusahaan. Kesmas Natl Public Heal J. 2014;9(2):113. doi:10.21109/kesmas.v9i2.499
   Google Scholar
• Inayati Rakhmat I, Jusuf H, Rachmanita S. Prevalence and Characteristics of Metabolic Syndrome Patients in Cibeber Village Cimahi Indonesia. J Heal Dent Sci. 2021;1(Volume 1 No 1):56.
   Google Scholar
• Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):1–8. doi:10.1007/s11906-018-0812-z
   PubMed Web of Science ®Google Scholar
• Jahangiry L, Khosravi-Far L, Sarbakhsh P, Kousha A, Entezarmahdi R, Ponnet K. Prevalence of metabolic syndrome and its determinants among Iranian adults: evidence of IraPEN survey on a bi-ethnic population. Sci Rep. 2019;9(1):1–7. doi:10.1038/s41598-019-44486-8
   PubMedGoogle Scholar
• Alowfi A, Binladen S, Irqsous S, Khashoggi A, Khan MA, Calacattawi R. Metabolic syndrome: prevalence and risk factors among adolescent female intermediate and secondary students in Saudi Arabia. Int J Environ Res Public Health. 2021;18(4):1–13. doi:10.3390/ijerph18042142
   Web of Science ®Google Scholar
• Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a Metabolic Syndrome Phenotype in Adolescents. Arch Pediatr Adolesc Med. 2003;157(8):821. doi:10.1001/archpedi.157.8.821
   PubMedGoogle Scholar
• Elabbassi WN, Haddad HA. The epidemic of the metabolic syndrome. Saudi Med J. 2005;26(3):373–375.
   PubMed Web of Science ®Google Scholar